Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
Kristofer Andréasson, Roger Hesselstrand, Section of Rheumatology, Department of Clinical Sciences Lund, Lund University, Lund S-221 85, Sweden
Göran Jönsson, Hans Norrgren, Section of Infectious Diseases, Department of Clinical Sciences Lund, Lund University, Lund S-221 85, Sweden
Author contributions: Andréasson K, Jönsson G, Hesselstrand R and Norrgren H designed the study and wrote this letter; Norrgren H is in charge of the patients and performed the Fibroscan analyses; Andréasson K made the statistical analyses.
Supported by: Bengt Ihre Foundation, No. SLS-594-301 and SLS-789091.
Conflict-of-interest statement: The authors declare that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Kristofer Andréasson, MD, PhD, Reader (Associate Professor), Section of Rheumatology, Department of Clinical Sciences Lund, Lund University, Kioskgatan 3, Lund S-221 85, Sweden. firstname.lastname@example.org
Telephone: +46-46-171000 Fax: +46-46-128468
Received: January 13, 2019
Peer-review started: January 14, 2019
First decision: February 22, 2019
Revised: February 27, 2019
Accepted: March 16, 2019
Article in press: March 16, 2019
Published online: March 27, 2019